Rare diseases
Investigational molecules
Locations
-, 51368 Leverkusen, Germany
Non-small cell lung cancer, solid tumors, and prostate cancer are prominent areas of interest, including disease settings defined by EGFR, HER2, NTRK fusion, KRAS G12C, and MTAP deletion. Research also extends to hepatocellular carcinoma and metastatic disease.
Interest includes both precision oncology and treatment strategies for advanced, refractory, and biomarker-defined cancers.
Bayer AG runs clinical trials in conditions such as Chronic kidney disease, Neoplasm malignant, Menopausal symptoms, Magnetic resonance imaging, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Efficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study
BelgiumA study of finerenone with standard treatment for children and young adults from birth to 18 years with heart failure and left ventricular systolic dysfunction
AustriaA study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function
AustriaA study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors
BelgiumStudy on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations
DenmarkStudy on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria
AustriaStudy on How Gadoquatrane Works and Its Safety in Children Undergoing MRI Scans
BulgariaA Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome
CzechiaStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
AustriaA study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.
GermanyBioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms
GermanyRelative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
